In this work, we find that blockade of KCNH6 channels by BBR increases insulin secretion in a high-glucose-dependent manner or only under hyperglycemic conditions, suggesting that BBR is a glucose-dependent insulin secretagogue for the treatment of diabetes that does not cause hypoglycemia. Here, INS is linked to diabetes mellitus.